FindTrial
Sign In

A short duration interview based study conducted on the Chronic Myeloid Leukemia patients at single site in order to determine the compliance / adherence to their medication Imatinib Mesylate and to find out the factors causing the non compliance / non adherence to the Imatinib Mesylate

A pilot study to determine the Imatinib adherence in CML patients and to find out the factors associated with non adherence : Single Centre Observational Questionnaire Based Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/02/003427
Enrollment
100
Registered
2013-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Myeloid Leukemia Health Condition 2: C921- Chronic myeloid leukemia, BCR/ABL-positive

Interventions

Intervention1: Questionnaires used are : - 9 item Morisky Medication Adherence Scale - Additional questionnaire ( consisting of patient demographics , factors influencing the medication adherence in C

Sponsors

Jyotsna Kapoor
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. willing to consent for participation in the study. 2. Patients diagnosed with CML atleast 3 months from the start of the study. 3.Treatment with Imatinib 4. Those who can understand Hindi or English

Exclusion criteria

Exclusion criteria: 1. Patients who are either Dumb or deaf 2. patients who have undergone allogenic stem cell transplantation 3. patients taking another tyrosine kinase inhibitors besides Imatinib Mesylate

Design outcomes

Primary

MeasureTime frame
To determine Imatinib Mesylate adherence in CML patientsTimepoint: May 2013 - june 2013—

Secondary

MeasureTime frame
1)To find out the factors associated with non adherence to medication 2)To suggest measures to improve the non adherence of the medication in CML patients 3)To inform the patients about the importance of the adherence to their medication to improve their health. Timepoint: 5 months—

Countries

India

Contacts

Public ContactJyotsna Kapoor

Rajiv Gandhi Cancer Institute and Research Centre

bhurani.dinesh@rgcirc.org9971500861

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026